Ampicillin–Sulbactam and Amikacin Used as Second-Line Antibiotics for Patients with Culture-Negative Peritonitis

Abstract

Get full access to this article

View all access options for this article.

References

Piraino

, Bailie

G.R.

, Bernardini

, Boeschoten

, Gupta

, Holmes

; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107–31.

Yoo

T.H.

, Chang

K.H.

, Ryu

D.R.

, Kim

J.S.

, Choi

H.Y.

, Park

H.C.

Usefulness of 23S rRNA amplification by PCR in the detection of bacteria in CAPD peritonitis.

Am J Nephrol 2006; 26: 115–20.

Barry

A.L.

, Jones

R.N.

In vitro activities of ampicillinsulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.

Antimicrob Agents Chemother 1990; 34: 1830–2.

Ramos

M.C.

, Ing

, Kim

, Witt

M.D.

, Bayer

A.S.

Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.

Antimicrob Agents Chemother 1996; 40: 97–101.

Troidle

, Gorban-Brennan

, Kliger

, Finkelstein

Differing outcomes of gram-positive and gram-negative peritonitis.

Am J Kidney Dis 1998; 32: 623–8.

Szeto

C.C.

, Wong

T.Y.

, Chow

K.M.

, Leung

C.B.

, Li

P.K.

The clinical course of culture-negative peritonitis complicating peritoneal dialysis.

Am J Kidney Dis 2003; 42: 567–74.